ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anthelmintic Drugs Market Research Report 2024
Published Date: March 2024
|
Report Code: QYRE-Auto-1P13967
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anthelmintic Drugs Market Research Report 2023
BUY CHAPTERS

Global Anthelmintic Drugs Market Research Report 2024

Code: QYRE-Auto-1P13967
Report
March 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bayer
Cipla Ltd
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson

Anthelmintic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anthelmintic Drugs Market

Anthelmintic Drugs Market

Anthelmintics are drugs that work on helminths as either vermicides (by killing) or vermifuges (by expelling).
The global Anthelmintic Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anthelmintic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anthelmintic Drugs.

Report Scope

The Anthelmintic Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Anthelmintic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anthelmintic Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anthelmintic Drugs Market Report

Report Metric Details
Report Name Anthelmintic Drugs Market
CAGR 5%
Segment by Type
  • Oral Drugs
  • Injectables
Segment by Application
  • For Human
  • For Animal
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Novartis, Pfizer, Bayer, Cipla, Sun Pharmaceutical Industries, Mankind Pharma, Johnson & Johnson, Merck
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Anthelmintic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Anthelmintic Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anthelmintic Drugs Market report?

Ans: The main players in the Anthelmintic Drugs Market are Novartis, Pfizer, Bayer, Cipla, Sun Pharmaceutical Industries, Mankind Pharma, Johnson & Johnson, Merck

What are the Application segmentation covered in the Anthelmintic Drugs Market report?

Ans: The Applications covered in the Anthelmintic Drugs Market report are For Human, For Animal

What are the Type segmentation covered in the Anthelmintic Drugs Market report?

Ans: The Types covered in the Anthelmintic Drugs Market report are Oral Drugs, Injectables

1 Anthelmintic Drugs Market Overview
1.1 Product Overview and Scope of Anthelmintic Drugs
1.2 Anthelmintic Drugs Segment by Type
1.2.1 Global Anthelmintic Drugs Market Value Comparison by Type (2024-2030)
1.2.2 Oral Drugs
1.2.3 Injectables
1.3 Anthelmintic Drugs Segment by Application
1.3.1 Global Anthelmintic Drugs Market Value by Application: (2024-2030)
1.3.2 For Human
1.3.3 For Animal
1.4 Global Anthelmintic Drugs Market Size Estimates and Forecasts
1.4.1 Global Anthelmintic Drugs Revenue 2019-2030
1.4.2 Global Anthelmintic Drugs Sales 2019-2030
1.4.3 Global Anthelmintic Drugs Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Anthelmintic Drugs Market Competition by Manufacturers
2.1 Global Anthelmintic Drugs Sales Market Share by Manufacturers (2019-2024)
2.2 Global Anthelmintic Drugs Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Anthelmintic Drugs Average Price by Manufacturers (2019-2024)
2.4 Global Anthelmintic Drugs Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Anthelmintic Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Anthelmintic Drugs, Product Type & Application
2.7 Anthelmintic Drugs Market Competitive Situation and Trends
2.7.1 Anthelmintic Drugs Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Anthelmintic Drugs Players Market Share by Revenue
2.7.3 Global Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Anthelmintic Drugs Retrospective Market Scenario by Region
3.1 Global Anthelmintic Drugs Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Anthelmintic Drugs Global Anthelmintic Drugs Sales by Region: 2019-2030
3.2.1 Global Anthelmintic Drugs Sales by Region: 2019-2024
3.2.2 Global Anthelmintic Drugs Sales by Region: 2025-2030
3.3 Global Anthelmintic Drugs Global Anthelmintic Drugs Revenue by Region: 2019-2030
3.3.1 Global Anthelmintic Drugs Revenue by Region: 2019-2024
3.3.2 Global Anthelmintic Drugs Revenue by Region: 2025-2030
3.4 North America Anthelmintic Drugs Market Facts & Figures by Country
3.4.1 North America Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Anthelmintic Drugs Sales by Country (2019-2030)
3.4.3 North America Anthelmintic Drugs Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Anthelmintic Drugs Market Facts & Figures by Country
3.5.1 Europe Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Anthelmintic Drugs Sales by Country (2019-2030)
3.5.3 Europe Anthelmintic Drugs Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Anthelmintic Drugs Market Facts & Figures by Country
3.6.1 Asia Pacific Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Anthelmintic Drugs Sales by Country (2019-2030)
3.6.3 Asia Pacific Anthelmintic Drugs Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Anthelmintic Drugs Market Facts & Figures by Country
3.7.1 Latin America Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Anthelmintic Drugs Sales by Country (2019-2030)
3.7.3 Latin America Anthelmintic Drugs Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Anthelmintic Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Anthelmintic Drugs Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Anthelmintic Drugs Sales by Country (2019-2030)
3.8.3 Middle East and Africa Anthelmintic Drugs Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Anthelmintic Drugs Sales by Type (2019-2030)
4.1.1 Global Anthelmintic Drugs Sales by Type (2019-2024)
4.1.2 Global Anthelmintic Drugs Sales by Type (2025-2030)
4.1.3 Global Anthelmintic Drugs Sales Market Share by Type (2019-2030)
4.2 Global Anthelmintic Drugs Revenue by Type (2019-2030)
4.2.1 Global Anthelmintic Drugs Revenue by Type (2019-2024)
4.2.2 Global Anthelmintic Drugs Revenue by Type (2025-2030)
4.2.3 Global Anthelmintic Drugs Revenue Market Share by Type (2019-2030)
4.3 Global Anthelmintic Drugs Price by Type (2019-2030)
5 Segment by Application
5.1 Global Anthelmintic Drugs Sales by Application (2019-2030)
5.1.1 Global Anthelmintic Drugs Sales by Application (2019-2024)
5.1.2 Global Anthelmintic Drugs Sales by Application (2025-2030)
5.1.3 Global Anthelmintic Drugs Sales Market Share by Application (2019-2030)
5.2 Global Anthelmintic Drugs Revenue by Application (2019-2030)
5.2.1 Global Anthelmintic Drugs Revenue by Application (2019-2024)
5.2.2 Global Anthelmintic Drugs Revenue by Application (2025-2030)
5.2.3 Global Anthelmintic Drugs Revenue Market Share by Application (2019-2030)
5.3 Global Anthelmintic Drugs Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Novartis Anthelmintic Drugs Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Pfizer Anthelmintic Drugs Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Corporation Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Bayer Anthelmintic Drugs Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Cipla
6.4.1 Cipla Corporation Information
6.4.2 Cipla Description and Business Overview
6.4.3 Cipla Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Cipla Anthelmintic Drugs Product Portfolio
6.4.5 Cipla Recent Developments/Updates
6.5 Sun Pharmaceutical Industries
6.5.1 Sun Pharmaceutical Industries Corporation Information
6.5.2 Sun Pharmaceutical Industries Description and Business Overview
6.5.3 Sun Pharmaceutical Industries Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sun Pharmaceutical Industries Anthelmintic Drugs Product Portfolio
6.5.5 Sun Pharmaceutical Industries Recent Developments/Updates
6.6 Mankind Pharma
6.6.1 Mankind Pharma Corporation Information
6.6.2 Mankind Pharma Description and Business Overview
6.6.3 Mankind Pharma Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Mankind Pharma Anthelmintic Drugs Product Portfolio
6.6.5 Mankind Pharma Recent Developments/Updates
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Anthelmintic Drugs Product Portfolio
6.7.5 Johnson & Johnson Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Anthelmintic Drugs Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Anthelmintic Drugs Product Portfolio
6.8.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Anthelmintic Drugs Industry Chain Analysis
7.2 Anthelmintic Drugs Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Anthelmintic Drugs Production Mode & Process
7.4 Anthelmintic Drugs Sales and Marketing
7.4.1 Anthelmintic Drugs Sales Channels
7.4.2 Anthelmintic Drugs Distributors
7.5 Anthelmintic Drugs Customers
8 Anthelmintic Drugs Market Dynamics
8.1 Anthelmintic Drugs Industry Trends
8.2 Anthelmintic Drugs Market Drivers
8.3 Anthelmintic Drugs Market Challenges
8.4 Anthelmintic Drugs Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Bayer
Cipla Ltd
Sun Pharmaceutical Industries
Mankind Pharma
Johnson & Johnson
List of Tables
    Table 1. Global Anthelmintic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Anthelmintic Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Anthelmintic Drugs Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Anthelmintic Drugs Sales (K Units) of Key Manufacturers (2019-2024)
    Table 5. Global Anthelmintic Drugs Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Anthelmintic Drugs Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Anthelmintic Drugs Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Anthelmintic Drugs Average Price (USD/Unit) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Anthelmintic Drugs, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Anthelmintic Drugs, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Anthelmintic Drugs, Product Type & Application
    Table 12. Global Key Manufacturers of Anthelmintic Drugs, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Anthelmintic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anthelmintic Drugs as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Anthelmintic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Anthelmintic Drugs Sales by Region (2019-2024) & (K Units)
    Table 18. Global Anthelmintic Drugs Sales Market Share by Region (2019-2024)
    Table 19. Global Anthelmintic Drugs Sales by Region (2025-2030) & (K Units)
    Table 20. Global Anthelmintic Drugs Sales Market Share by Region (2025-2030)
    Table 21. Global Anthelmintic Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Anthelmintic Drugs Revenue Market Share by Region (2019-2024)
    Table 23. Global Anthelmintic Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Anthelmintic Drugs Revenue Market Share by Region (2025-2030)
    Table 25. North America Anthelmintic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Anthelmintic Drugs Sales by Country (2019-2024) & (K Units)
    Table 27. North America Anthelmintic Drugs Sales by Country (2025-2030) & (K Units)
    Table 28. North America Anthelmintic Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Anthelmintic Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Anthelmintic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Anthelmintic Drugs Sales by Country (2019-2024) & (K Units)
    Table 32. Europe Anthelmintic Drugs Sales by Country (2025-2030) & (K Units)
    Table 33. Europe Anthelmintic Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Anthelmintic Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Anthelmintic Drugs Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Anthelmintic Drugs Sales by Region (2019-2024) & (K Units)
    Table 37. Asia Pacific Anthelmintic Drugs Sales by Region (2025-2030) & (K Units)
    Table 38. Asia Pacific Anthelmintic Drugs Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Anthelmintic Drugs Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Anthelmintic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Anthelmintic Drugs Sales by Country (2019-2024) & (K Units)
    Table 42. Latin America Anthelmintic Drugs Sales by Country (2025-2030) & (K Units)
    Table 43. Latin America Anthelmintic Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Anthelmintic Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Anthelmintic Drugs Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Anthelmintic Drugs Sales by Country (2019-2024) & (K Units)
    Table 47. Middle East & Africa Anthelmintic Drugs Sales by Country (2025-2030) & (K Units)
    Table 48. Middle East & Africa Anthelmintic Drugs Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Anthelmintic Drugs Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Anthelmintic Drugs Sales (K Units) by Type (2019-2024)
    Table 51. Global Anthelmintic Drugs Sales (K Units) by Type (2025-2030)
    Table 52. Global Anthelmintic Drugs Sales Market Share by Type (2019-2024)
    Table 53. Global Anthelmintic Drugs Sales Market Share by Type (2025-2030)
    Table 54. Global Anthelmintic Drugs Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Anthelmintic Drugs Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Anthelmintic Drugs Revenue Market Share by Type (2019-2024)
    Table 57. Global Anthelmintic Drugs Revenue Market Share by Type (2025-2030)
    Table 58. Global Anthelmintic Drugs Price (USD/Unit) by Type (2019-2024)
    Table 59. Global Anthelmintic Drugs Price (USD/Unit) by Type (2025-2030)
    Table 60. Global Anthelmintic Drugs Sales (K Units) by Application (2019-2024)
    Table 61. Global Anthelmintic Drugs Sales (K Units) by Application (2025-2030)
    Table 62. Global Anthelmintic Drugs Sales Market Share by Application (2019-2024)
    Table 63. Global Anthelmintic Drugs Sales Market Share by Application (2025-2030)
    Table 64. Global Anthelmintic Drugs Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Anthelmintic Drugs Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Anthelmintic Drugs Revenue Market Share by Application (2019-2024)
    Table 67. Global Anthelmintic Drugs Revenue Market Share by Application (2025-2030)
    Table 68. Global Anthelmintic Drugs Price (USD/Unit) by Application (2019-2024)
    Table 69. Global Anthelmintic Drugs Price (USD/Unit) by Application (2025-2030)
    Table 70. Novartis Corporation Information
    Table 71. Novartis Description and Business Overview
    Table 72. Novartis Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 73. Novartis Anthelmintic Drugs Product
    Table 74. Novartis Recent Developments/Updates
    Table 75. Pfizer Corporation Information
    Table 76. Pfizer Description and Business Overview
    Table 77. Pfizer Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 78. Pfizer Anthelmintic Drugs Product
    Table 79. Pfizer Recent Developments/Updates
    Table 80. Bayer Corporation Information
    Table 81. Bayer Description and Business Overview
    Table 82. Bayer Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 83. Bayer Anthelmintic Drugs Product
    Table 84. Bayer Recent Developments/Updates
    Table 85. Cipla Corporation Information
    Table 86. Cipla Description and Business Overview
    Table 87. Cipla Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 88. Cipla Anthelmintic Drugs Product
    Table 89. Cipla Recent Developments/Updates
    Table 90. Sun Pharmaceutical Industries Corporation Information
    Table 91. Sun Pharmaceutical Industries Description and Business Overview
    Table 92. Sun Pharmaceutical Industries Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 93. Sun Pharmaceutical Industries Anthelmintic Drugs Product
    Table 94. Sun Pharmaceutical Industries Recent Developments/Updates
    Table 95. Mankind Pharma Corporation Information
    Table 96. Mankind Pharma Description and Business Overview
    Table 97. Mankind Pharma Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 98. Mankind Pharma Anthelmintic Drugs Product
    Table 99. Mankind Pharma Recent Developments/Updates
    Table 100. Johnson & Johnson Corporation Information
    Table 101. Johnson & Johnson Description and Business Overview
    Table 102. Johnson & Johnson Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 103. Johnson & Johnson Anthelmintic Drugs Product
    Table 104. Johnson & Johnson Recent Developments/Updates
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Business Overview
    Table 107. Merck Anthelmintic Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
    Table 108. Merck Anthelmintic Drugs Product
    Table 109. Merck Recent Developments/Updates
    Table 110. Key Raw Materials Lists
    Table 111. Raw Materials Key Suppliers Lists
    Table 112. Anthelmintic Drugs Distributors List
    Table 113. Anthelmintic Drugs Customers List
    Table 114. Anthelmintic Drugs Market Trends
    Table 115. Anthelmintic Drugs Market Drivers
    Table 116. Anthelmintic Drugs Market Challenges
    Table 117. Anthelmintic Drugs Market Restraints
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Anthelmintic Drugs
    Figure 2. Global Anthelmintic Drugs Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Anthelmintic Drugs Market Share by Type in 2023 & 2030
    Figure 4. Oral Drugs Product Picture
    Figure 5. Injectables Product Picture
    Figure 6. Global Anthelmintic Drugs Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 7. Global Anthelmintic Drugs Market Share by Application in 2023 & 2030
    Figure 8. For Human
    Figure 9. For Animal
    Figure 10. Global Anthelmintic Drugs Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 11. Global Anthelmintic Drugs Market Size (2019-2030) & (US$ Million)
    Figure 12. Global Anthelmintic Drugs Sales (2019-2030) & (K Units)
    Figure 13. Global Anthelmintic Drugs Average Price (USD/Unit) & (2019-2030)
    Figure 14. Anthelmintic Drugs Report Years Considered
    Figure 15. Anthelmintic Drugs Sales Share by Manufacturers in 2023
    Figure 16. Global Anthelmintic Drugs Revenue Share by Manufacturers in 2023
    Figure 17. The Global 5 and 10 Largest Anthelmintic Drugs Players: Market Share by Revenue in 2023
    Figure 18. Anthelmintic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 19. Global Anthelmintic Drugs Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 20. North America Anthelmintic Drugs Sales Market Share by Country (2019-2030)
    Figure 21. North America Anthelmintic Drugs Revenue Market Share by Country (2019-2030)
    Figure 22. U.S. Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 23. Canada Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 24. Europe Anthelmintic Drugs Sales Market Share by Country (2019-2030)
    Figure 25. Europe Anthelmintic Drugs Revenue Market Share by Country (2019-2030)
    Figure 26. Germany Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 27. France Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 28. U.K. Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Italy Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Russia Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Anthelmintic Drugs Sales Market Share by Region (2019-2030)
    Figure 32. Asia Pacific Anthelmintic Drugs Revenue Market Share by Region (2019-2030)
    Figure 33. China Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. Japan Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. South Korea Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. India Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Australia Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 38. Taiwan Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 39. Indonesia Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Thailand Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. Malaysia Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. Philippines Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Latin America Anthelmintic Drugs Sales Market Share by Country (2019-2030)
    Figure 44. Latin America Anthelmintic Drugs Revenue Market Share by Country (2019-2030)
    Figure 45. Mexico Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Brazil Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Argentina Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Middle East & Africa Anthelmintic Drugs Sales Market Share by Country (2019-2030)
    Figure 49. Middle East & Africa Anthelmintic Drugs Revenue Market Share by Country (2019-2030)
    Figure 50. Turkey Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 51. Saudi Arabia Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. U.A.E Anthelmintic Drugs Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Global Sales Market Share of Anthelmintic Drugs by Type (2019-2030)
    Figure 54. Global Revenue Market Share of Anthelmintic Drugs by Type (2019-2030)
    Figure 55. Global Anthelmintic Drugs Price (USD/Unit) by Type (2019-2030)
    Figure 56. Global Sales Market Share of Anthelmintic Drugs by Application (2019-2030)
    Figure 57. Global Revenue Market Share of Anthelmintic Drugs by Application (2019-2030)
    Figure 58. Global Anthelmintic Drugs Price (USD/Unit) by Application (2019-2030)
    Figure 59. Anthelmintic Drugs Value Chain
    Figure 60. Anthelmintic Drugs Production Process
    Figure 61. Channels of Distribution (Direct Vs Distribution)
    Figure 62. Distributors Profiles
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Anthelmintics for Animals Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antihelminthics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Albendazole Anthelmintic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Injectable Anthelmintic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Anti worm Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti helminthic Drugs Market Research Report 2024
Global Antiparasitic Drugs for Dogs Market Research Report 2024
Global Antiparasitic Drugs for Pets Market Research Report 2025
Global Anthelmintics for Dogs and Cats Market Insights Forecast to 2030
Global Animal Parasite Prevention and Control Drugs Market Research Report 2025
Global Ectoparasiticides Market Insights Forecast to 2030
Global Companion Animal Anthelmintics Market Research Report 2024
Dog Deworming Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Home Pet Deworming Medicine Market Research Report 2024
Cat Deworming Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pet Dewormers Market Insights Forecast to 2030
Global Endoparasiticide Market Research Report 2024
Global Helminthic Infestations Therapeutics Market Research Report 2024
Global Cattle Parasiticides Market Research Report 2025
Global Ivermectin Medication Market Insights Forecast to 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions